General Information of the Compound
| Compound ID |
CP0570246
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-10-[[5-chloro-2-[(3S)-4,4-difluoro-3-hydroxypiperidin-1-yl]pyrimidin-4-yl]amino]-2-cyclopropyl-3,3-difluoro-7-methyl-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-6-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H25ClF4N6O3
|
||||||||||||||||||
| Molecular Weight |
568.959
|
||||||||||||||||||
| Canonical SMILES |
Cn1c2ccc(Nc3nc(ncc3Cl)N3CCC(F)(F)[C@@H](O)C3)cc2c2N[C@@H](C3CC3)C(F)(F)COc2c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H25ClF4N6O3/c1-35-16-5-4-13(32-21-15(26)9-31-23(34-21)36-7-6-24(27,28)17(37)10-36)8-14(16)18-19(22(35)38)39-11-25(29,30)20(33-18)12-2-3-12/h4-5,8-9,12,17,20,33,37H,2-3,6-7,10-11H2,1H3,(H,31,32,34)/t17-,20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VMGLHACLWFOJMH-PXNSSMCTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound